Rituximab decreases the risk of lymphoma in patients with HTV-associated multicentric Castleman disease. - Gérard, Laurence; Michot, Jean-Marie; Burcheri, Sara; Fieschi, Claire; Longuet, Pacale; Delcey, Véronique; Meignin, Véronique; Agbalika, Felix; Chevret, Sylvie; Oksenhendler, Eric; Galicier, Lionel (Blood, 2012)